Patent · US Active

Pyrrolotriazines as ALK inhibitors

US9440984B2 · kind B2 · utility

0Cited by
2References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 2015
Grant dateSep 13, 2016
Priority date—
Expiry dateNov 18, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application provides compounds of the general formula (I)and/or a salt thereof, where X, R1 and R2 are as defined herein. Compositions and therapeutic uses are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.